Treatment Options in the Management of Status Epilepticus

Status epilepticus treatment involves the use of several pharmacologic compounds, which are conceptually divided into three successive and additional lines of action. Because of their rapid onset of action, benzodiazepines represent the first approach; these are followed by classic antiepileptic drugs that are administered intravenously. In refractory episodes, pharmacologic coma induction with an appropriate anesthetic is advocated. Apart from first-line compounds, the level of evidence for medications used in status epilepticus is extremely limited. It is important to specifically address etiology in order to maximize the impact of the antiepileptic therapy. Fine-tuning of the treatment strategy, mainly regarding the choice of whether to induce coma, should be approached by balancing the benefits of rapid control of the status epilepticus with the risks of adverse effects. Although each status epilepticus episode should be treated as rapidly as possible, it appears advisable to reserve coma induction for those forms, such as generalized convulsive status, that have been shown to present a consistent risk of neurologic sequelae.

Ansiedad y Depresión: Consulta de enfermería de Atención Primaria

La alta prevalencia de los trastornos mentales se relaciona con las transformaciones de nuestra sociedad, la falta de apoyo familiar y social, la soledad, el aumento de las patologías orgánicas crónicas relacionadas con el aumento de la esperanza de vida y el envejecimiento de la población. La revista científica Lancet, en septiembre de 2007, publicó un informe donde alerta sobre el aumento progresivo de los trastornos mentales, convirtiéndose en la enfermedad no contagiosa más extendida en el mundo, además añaden que estos problemas de salud mental incrementan el riesgo de desarrollar enfermedades físicas, como problemas del corazón, cáncer, infecciones, etc. Según la OMS, los trastornos mentales de ansiedad y depresión se encuentran entre los trastornos psiquiátricos de mayor prevalencia, aunque hay variaciones culturales en su incidencia. En numerosas ocasiones, provocan una discapacidad importante, sufrimiento y limitaciones en las actividades de la vida diaria a las personas que las padecen.

Outcome of severe unilateral cerebellar hypoplasia.

Aim: Complete or subtotal absence of one cerebellar hemisphere is exceptional; only single cases have been described. We aimed to assess the long-term outcome in children with severe unilateral cerebellar hypoplasia (UCH). Method: As part of a retrospective study we describe neuroimaging features, clinical findings, and cognitive outcomes of seven children with UCH (five males, two females; age at first magnetic resonance imaging [MRI]: median 1y 3mo, range 9d-8y 10mo; age at latest follow-up: median 6y 6mo, range 2y 3mo-14y 11mo). Results: One child had abnormalities on prenatal MRI at 21 weeks' gestation. The left cerebellar hemisphere was affected in five children, and the right hemisphere in two children. The vermis was involved in five children. The volume of the posterior fossa was variable. At the latest follow-up, neurological findings included truncal ataxia and muscular hypotonia in five children, limb ataxia in three patients, and head nodding in two patients. Three children had learning disability*, five had speech and language disorders, and one had a severe behavioural disorder. Interpretation: Severe UCH is a residual change after a disruptive prenatal cerebellar insult, most likely haemorrhagic. The outcome is variable, ranging from almost normal development to marked developmental impairment. Ataxia is a frequent but not a leading sign. It seems that involvement of the cerebellar vermis is often, but not consistently, associated with a poorer cognitive outcome, whereas an intact vermis is associated with normal outcome and no truncal ataxia.

Sudden unexpected death in an infant with L-2-hydroxyglutaric aciduria.

Inherited metabolic disorders are the cause of a small but significant number of sudden unexpected deaths in infancy. We report a girl who suddenly died at 11 months of age, during an intercurrent illness. Autopsy showed spongiform lesions in the subcortical white matter, in the basal ganglia, and in the dentate nuclei. Investigations in an older sister with developmental delay, ataxia, and tremor revealed L-2-hydroxyglutaric aciduria and subcortical white matter changes with hyperintensity of the basal ganglia and dentate nuclei at brain magnetic resonance imaging. Both children were homozygous for a splice site mutation in the L2HGDH gene. Sudden death has not been reported in association with L-2-hydroxyglutaric aciduria so far, but since this inborn error of metabolism is potentially treatable, early diagnosis may be important.

Second-line status epilepticus treatment: comparison of phenytoin, valproate, and levetiracetam.

Purpose:  Phenytoin (PHT), valproic acid (VPA), or levetiracetam (LEV) are commonly used as second-line treatment of status epilepticus (SE), but comparative studies are not available. Methods:  Among 279 adult SE episodes identified prospectively in our tertiary care hospital over 4 years, we retrospectively identified 187 episodes in which PHT, VPA, or LEV were given after benzodiazepines. Patients with postanoxic SE were not included. Demographics, clinical SE features, failure of second-line treatment to control SE, new handicap, and mortality at hospital discharge were assessed. Uni- and multivariable statistical analyses were applied to compare the three agents. Key Findings:  Each compound was used in about one third of SE episodes. VPA failed to control SE in 25.4%, PHT in 41.4%, and LEV in 48.3% of episodes in which these were prescribed. A deadly etiology was more frequent in the VPA group, whereas SE episodes tended to be more severe in the PHT group. After adjustment for these known SE outcome predictors, LEV failed more often than VPA [odds ratio (OR) 2.69; 95% confidence interval (CI) 1.19-6.08]; 16.8% (95% CI: 6.0-31.4%) of second-line treatment failures could be attributed to LEV. PHT was not statistically different from the other two compounds. Second-line treatment did not seem to influence new handicap and mortality, whereas etiology and the SE Severity Score (STESS) were robust independent predictors. Significance:  Even without significant differences on outcome at discharge, LEV seems less efficient than VPA to control SE after benzodiazepines. A prospective comparative trial is needed to address this potentially concerning finding.

Soil oribatid mite in four typical vegetation communities of Misiones forest in the Iguazú area, Argentina

The objective of this work was to assess the soil oribatid mite communities in four sites of the Upper Paraná Bosque Atlántico, in the Iguazú National Park, Argentina and in surrounding areas: bamboo forest, palm forest and two mixed forests. A comparison between each pair of sites, based on the presence-absence of oribatid species, was performed using Jaccard's index. This is the first systematic sampling of oribatid mites in this area. A total of 56 genera and 96 oribatid species were found, 25 and 49 of them, respectively, are new citation for Argentina. The highest similarity was found between mixed forests. Almost 68% and 34% of the genera were cited for similar biotopes in Brazil and Paraguay, respectively.

Rapid Improvement and Maintenance of the Lipid Profile After Roux-en-Y Gastric Bypass (RYGBP)

Background: Dyslipidemia, a major component of the metabolic syndrome and an important cardiovascular risk factor, is one of the commonest comorbidity associated with morbid obesity. The aim of this paper is to show that RYGBP markedly improves dyslipidemia and that this improvement maintains over time. Patients and Methods: Prospectively updated databank for bariatric patients. Patients undergoing RYGBP have yearly blood tests during follow-up. The results for lipids at one to five years were compared with preoperative values. Results: The mean excess BMI loss after one and five years was 77,9 % and 72,3%respectively. After one year, there was a significant reduction of the mean total cholesterol, LDL-cholesterol, total cholesterol/HDL ratio and triglyceride values, which maintained up to five years, and an increase of the HDL fraction, which progressed until five years. The proportion of patients with abnormal values decreased from 24,3 to 6,2% for total cholesterol, from 45,1 to 11,7 %for HDL, from 53,3 to 21,9 for LDL, and from 40,5 to 10 % for triglycerides, with no significant change between three and five years, despite some weight regain. Conclusions: RYGBP rapidly improves all components of dyslipidemia, and thereby reduces the overall cardiovascular risk in operated patients.

Medidas corporales y concentración sérica y folicular de lípidos y glucosa en vacas Brahman fértiles y subfértiles

El objetivo de este estudio fue evaluar las diferencias en las medidas corporales en vacas Brahman fértiles y subfértiles, establecer las diferencias en la concentración de colesterol, lipoproteínas y glucosa en suero y líquido folicular, y desarrollar un modelo para predecir subfertilidad en vacas Brahman a partir de las medidas corporales. Se seleccionaron vacas Brahman registradas, agrupadas en fértiles (15) y subfértiles (15) según historial reproductivo. Se tomaron muestras de suero y líquido folicular (diámetro >8 mm) para determinar colesterol, lipoproteínas, triacilgliceroles y glucosa. Las vacas subfértiles mostraron un fenotipo masculino, con medidas corporales mayores, y concentraciones de colesterol y HDL séricos y foliculares más bajas que las vacas fértiles. El colesterol y el HDL se correlacionaron positivamente entre los compartimientos en ambos grupos. La subfertilidad es más probable en vacas pesadas con hombros amplios y mayor perímetro torácico. El tamaño corporal en vacas Brahman subfértiles se relacionó con su apariencia, con cambios en los metabolitos séricos y foliculares y con las concentraciones de colesterol y HDL.

Crescimento vegetativo, floração e frutificação efetiva do pessegueiro 'Jubileu' submetido a diferentes comprimentos de interenxertos

O objetivo deste trabalho foi avaliar os efeitos do uso de interenxertos, com diferentes comprimentos, sobre o vigor de plantas de pessegueiro da cultivar Jubileu. Foram utilizados interenxertos da cultivar de baixo vigor, Granada, com 5, 10, 15 e 20 cm de comprimento. Avaliaram-se o crescimento vegetativo, a floração e a frutificação efetiva das plantas. O experimento foi conduzido em Pelotas, RS, de março de 2007 a dezembro de 2008. O crescimento vegetativo do pessegueiro 'Jubileu' está diretamente relacionado ao comprimento do interenxerto. O aumento do comprimento do interenxerto antecipa o início da floração e da plena floração. A redução do vigor, induzida por interenxertos de maior comprimento, promove aumento na diferenciação floral. O interenxerto com 20 cm intensifica a redução do vigor, mas aumenta a mortalidade das plantas. Portanto, os interenxertos com 10 e 15 cm de comprimento são os mais adequados para o adensamento de pomares.

Símptomes negatius i cognició social en l'esquizofrènia : un programa d'intervenció

L’esquizofrènia és un trastorn mental greu que afecta a un 1% de la població mundial. El seu tractament ha estat molt estudiat i, al llarg del temps, s’han descobert i fomentat noves línies de treball com són el tractament de la simptomatologia negativa i el dèficit cognitiu, front l’originària focalització en els símptomes positius. El present programa d’intervenció té com objectiu principal la millora de la simptomatologia negativa i el funcionament social en les persones diagnosticades d’esquizofrènia negativa. El programa es situa en el buit existent entre els programes de rehabilitació cognitiva (RC) i els programes de reinserció laboral i vocacionals donat que els actual programes d’entrenament en habilitats socials han demostrat no ser aplicables a la vida diària dels pacients esquizofrènics. El programa té un format grupal i una duració de 3 anys, amb una sessió setmanal, i consta de 4 mòduls diferenciats (Entrevista Motivacional, Cognició, Simptomatologia negativa i relacions socials, Cloenda i Recopilació de conceptes) amb objectius, dificultat i temporalitat diferents. Les possibles limitacions del programa vindrien donades per la dificultat de determinar quins són els pacients que s’adequarien a aquesta intervenció, pel que serà necessària la realització d’una adequada avaluació per seleccionar els membres del grup de tractament. Alhora, en la seva aplicació, les limitacions vindrien determinades per la forta implicació emocional i cohesió grupal que el programa requereix.

Evaluación de la calidad de vida en los pacientes con una malformación de Chiari tipo I. Estudio piloto en una cohorte de 67 pacientes

Introducción: La malformación de Chiari tipo I (MC-I) es una entidad de baja prevalencia, cuya clínica es muy variada dependiendo del cortejo malformativo asociado, y en la que pueden existir síntomas ansiosodepresivos y una pérdida no definida de la calidad de vida de los pacientes. El objetivo principal de este estudio es determinar la repercusión de la MC-I en la calidad de vida, así como la presencia de ansiedad y depresión en estos pacientes. Pacientes y métodos: Estudio prospectivo de una cohorte de 67 pacientes afectos de MC-I en los que se valoraron la calidad de vida, la presencia de ansiedad y síntomas depresivos mediante las escalas Sickness Impact Profile, inventario de ansiedad estado-rasgo e inventario de depresión de Beck, respectivamente. En cada paciente se registró la presencia de siringomielia o hidrocefalia, así como el grado de ectopia de las amígdalas del cerebelo. Resultados: El impacto de la MC-I en la calidad de vida fue nulo en seis pacientes (9%), leve en 36 (53,7%), moderado en 17 (25,4%) y grave en ocho (11,9%). El área de actividad más afectada fue el trabajo. El 86,6% de los pacientes presentó un nivel de ansiedad moderado o elevado. En el 25,4% de los pacientes también se constataron síntomas depresivos moderados o graves. Conclusiones: La gran mayoría de los pacientes con una MC-I considera que su enfermedad implica una pérdida de calidad de vida que, en muchos casos, se asocia a una alta ansiedad y a síntomas depresivos